Alex Toker
 | This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (October 2021) |
Prof. Alex Toker | |
|---|---|
| Alma mater | |
| Scientific career | |
| Fields | Biology, cell biology, apoptosis, Cancer |
| Institutions | |
Alex Toker is currently a professor at the Department of Pathology at Beth Israel Deaconess Medical Center, Harvard Medical School and Chief of the Division of Signal Transduction and Associate Director of the Cancer Research Institute in the Cancer Center.[1][2] Toker is an expert in the signaling mechanisms that govern cancer progression.[3] His research focus on understanding mechanism of cancer including tumor cell survival, invasion and metastasis. He is currently editor-in-chief of the Journal of Biological Chemistry.[4][5]
In 2022 Toker was the recipient of the Avanti Award in Lipids.[6]
References
[edit]- ^ "Home". www.tokerlab.com. Retrieved August 7, 2021.
- ^ "Alex Toker | Harvard Catalyst Profiles | Harvard Catalyst". connects.catalyst.harvard.edu. Retrieved August 7, 2021.
- ^ "ASBMB names 2022 award winners". www.asbmb.org. Retrieved January 8, 2024.
- ^ "Journal of Biological Chemistry names new editor-in-chief". www.asbmb.org. Retrieved August 7, 2021.
- ^ "Journal of Biological Chemistry". www.jbc.org. Retrieved August 7, 2021.
- ^ "Avanti Awards in Lipids". Avanti Polar Lipids (en-US). Retrieved January 8, 2024.
| Authority control databases: Academics |
|---|
   | This biographical article related to medicine in the United States is a stub. You can help Wikipedia by expanding it. |